Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMANDA J KAMAR

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1891291415
CMS profile
4270907
Location
CHICAGO, IL

General Payments · PY2019–2024

$3,743.25

  • Reported across 31 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,632.40

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,555.01 3
Food and Beverage $1,077.39 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $411.55 4
PY2020 $228.46 3
PY2021 $138.20 3
PY2022 $252.43 3
PY2023 $80.21 1
PY2024 $2,632.40 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $18.82 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139421097 CMS
AstraZeneca Pharmaceuticals LP $125.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104327222 CMS
AstraZeneca Pharmaceuticals LP $63.41 05/19/2024 Food and Beverage Undisputed 01/23/2026 1105756833 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.17 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118217637 CMS
GENZYME CORPORATION $94.42 03/14/2024 Food and Beverage Undisputed 01/23/2026 1139605103 CMS
Grifols USA, LLC $776.72 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1124743498 CMS
Grifols USA, LLC $78.21 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743500 CMS
Grifols USA, LLC $222.82 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743502 CMS
Grifols USA, LLC $76.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743504 CMS
Grifols USA, LLC $79.08 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743506 CMS
Grifols USA, LLC $58.71 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743508 CMS
Grifols USA, LLC $120.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743510 CMS
Grifols USA, LLC $55.70 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124743512 CMS
Grifols USA, LLC $583.12 03/06/2024 Travel and Lodging Undisputed 01/23/2026 1124743516 CMS
Grifols USA, LLC $195.17 03/15/2024 Travel and Lodging Undisputed 01/23/2026 1124743514 CMS
Merck Sharp & Dohme LLC $24.97 11/15/2024 Food and Beverage Undisputed 01/23/2026 1141587162 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.22 09/27/2024 Food and Beverage Undisputed 01/23/2026 1137593772 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.